-
SINTX Technologies (SINT) Misses Q3 EPS by 346c
-
SINTX receives FDA clearance for foot and ankle device, reports Q3 losses
-
SINTX Technologies launches OsseoSculpt biologic for foot surgeries
-
SINTX Technologies (SINT) files for 1.74M share offering by selling stockholders
-
SINTX Technologies receives FDA clearance for foot and ankle implant
-
SINTX Technologies receives FDA clearance for foot and ankle implant system
-
SINTX Technologies (SINT)
-
SINTX Technologies raises $3.8 million through warrant exercise
-
SINTX Technologies reports silicon nitride shows antiviral activity
-
SINTX completes SiNAPTIC acquisition, adds medical device leadership team
-
SINTX Technologies publishes study on silicon nitride trauma plates
-
SINTX submits FDA application for silicon nitride foot implants
-
SINTX Technologies (SINT) Acquires SiNAPTIC Surgical Assets and IP to Expand into $1.3B Foot and Ankle Fusion Market
-
SINTX Technologies (SINT) Announces Strategic Vision Focused on Expansion Across Key Sectors
-
SINTX Tech (SINT) PT Lowered to $28 at Ascendiant Capital
-
SINTX Technologies (SINT) Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market
-
SINTX Technologies (SINT) Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization
-
SINTX Technologies (SINT) Announces Strategic Changes to Board of Directors
-
SINTX Technologies (SINT) Files for 3M Share Offering by Selling Stockholders
-
SINTX Technologies (SINT) Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine Fusion
-
SINTX Technologies (SINT) Announces Board Chairman Transition
-
SINTX Technologies (SINT) Announces $5M Private Placement at $3.45/sh
-
SINTX Technologies (SINT) Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
-
SINTX Technologies (SINT) and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment
-
SINTX Technologies (SINT) Appoints Gregg R. Honigblum as Chief Strategy Officer
-
SINTX Technologies (SINT) Appoints Ryan Bock as CTO, Ann Kutsch as President of SINTX TA&T
-
SINTX Technologies (SINT) Announces Completion of $3.1 Million ATM Equity Public Offering
-
SINTX Technologies (SINT) Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
-
SINTX Technologies (SINT) Provides Strategic Update: Significant Cost Reductions, Extended Cash Runway, and Exploration of Strategic Partnerships
-
SINTX Technologies (SINT) Appoints Eric K. Olson as CEO
-
SINTX Technologies (SINT) To Explore Strategic Opportunities

